Pharmaceuticals

EU regulators disapprove GVK Bio’s clinical trials

06 Dec 2014

Aurobindo Pharma completes $132.5-m acquisition of US firm Natrol

06 Dec 2014

Merck & Co in talks to buy Cubist Pharmaceuticals for more than $7 bn

06 Dec 2014

Cubist Pharmaceuticals develops drugs for potentially life-threatening infections caused by dangerous bacteria categorised as serious and urgent public health threats

GSK abandons sale of older drugs portfolio

05 Dec 2014

British specialty pharma company BTG to buy PneumRx Inc for up to $475 mn

04 Dec 2014

After US, Germany bans Ranbaxy antibiotic from Dewas plant

04 Dec 2014

GlaxoSmithKline's $1.57-bn restructuring to hit US jobs

04 Dec 2014

GSK is struggling with declining sales, especially in the US, mainly due to a fall in its respiratory business, which accounted for 30 per cent of its global sales last year

Johnson & Johnson explores sale of artificial sweetener brand Splenda

04 Dec 2014

Japanese drugmaker Otsuka Holdings to buy Avanir Pharmaceuticals Inc for $3.5 bn

02 Dec 2014

Roche to acquire prenatal tester for risks in down syndrome Ariosa Diagnostics

02 Dec 2014

European regulator approves Medtronic-Covidien $42.9-bn deal

28 Nov 2014

Ebola virus gives birth to a new vaccine

28 Nov 2014

Over the long term, GlaxoSmithKline's new vaccine is intended to protect against all Ebola outbreaks, and the drug maker hopes to produce one million doses a month of the vaccine by the end of 2015

Dr Reddy's bulk drugs unit in Andhra gets US FDA fiat on procedural lapses

27 Nov 2014

Medtronic’s $42.9-bn Covidien deal approved by US regulator

27 Nov 2014

Medtronic Inc,  the world's fourth-largest medical device maker, has received US regulatory approval to acquire Dublin-based Covidien Plc, subject to the condition that it sells its drug-coated balloon catheter business

Bayer weighs sale of diabetes device business worth up to $2.5 bn

25 Nov 2014

Tata Memorial recommends 12 cancer drugs for price control

25 Nov 2014

BioMarin Pharmaceuticals to buy Dutch drug developer Prosensa for up to $840 mn

25 Nov 2014

Devices maker Stryker mulls $16-bn bid for British peer Smith & Nephew

25 Nov 2014

US medical device maker Stryker Corp is considering structuring the transaction as a tax inversion move, allowing it to move its base to the UK, where the taxes are lower than in the US

Royalty Pharma to buy cystic fibrosis drug from Cystic Fibrosis Foundation for $3.3 bn

20 Nov 2014

US court dumps Ranbaxy’s bid to stall launch of rival generics

20 Nov 2014

Ranbaxy’s move is seen as risky especially since the drug maker has been under regulatory probe for a long period now

Ranbaxy sues US FDA over revoking drug approvals

18 Nov 2014

Generic Nexium and Valcyte together would have contributed about $200 million to Ranbaxy's revenue in the first six months of market exclusivity, say analysts

Actavis in talks to buy US Botox maker Allergan for around $60 billion: report

13 Nov 2014

Last week Allergan had said it was in talks with a suitor, without identifying ithe bidder, which was widely speculated as being Actavis

Sweden’s ICA Gruppen to buy pharmacy chain Apotek Hjartat $770 million

12 Nov 2014

Indian pharma companies well positioned for global growth: S&P

12 Nov 2014

Aurobindo Pharma to buy US nutritional supplement maker Natrol for Rs 813 crore

12 Nov 2014